Prothena Announces Leadership Team Updates

Go back to Prothena Announces Leadership Team Updates

Prothena Corp (PRTA) PT Lowered to $31 at BofA Securities

October 1, 2024 6:05 AM UTC

BofA Securities analyst Tazeen Ahmad lowered the price target on Prothena Corp (NASDAQ: PRTA) to $31.00 (from $33.00) while maintaining a Neutral rating.

The analyst comments "We connected with management following the late Friday announcement that CMO, Hideki Garren, MD, PhD was leaving the company. Garren joined Roche as the new head of Neurology Product Development. CEO Gene Kinney stated that Garren has created a strong team at Prothena (PRTA). The company... More